Skip to main content

Advertisement

Log in

The effects of Ankaferd hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy

  • Correspondence
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Introduction

New agents are introduced each day to be used in the prevention and treatment of mucositis in cancer treatment. One of those agents is the Ankaferd hemostat. Ankaferd hemostat has pleiotropic effects and anti-infective characteristics in tissue healing.

Methods

The study was designed as a randomized controlled experimental study. The sample of the study comprised a total of 66 patients (33 patients in the Ankaferd hemostat group and 33 patients in the sodium bicarbonate group) with colorectal cancer who received FOLFOX combination chemotherapy treatment in the first cycle of chemotherapy to prevent mucositis. Participants who met the criteria were randomly assigned to the groups. Before the patient received chemotherapy, ECOG performance score and Oral Mucositis Grading Scale were applied on the 7th day and 15th day. The Ankaferd hemostat group brushed teeth at least twice a day for 2 min and gargled with Ankaferd hemostat twice for 2 min for 2 weeks. The sodium bicarbonate group brushed teeth at least 2 min a day and gargled with sodium bicarbonate 4 times for 2 min for 2 weeks. The Consolidated Standards of Reporting Trials diagram was used to illustrate the randomization of patients.

Results

When the Ankaferd hemostat group is compared with the sodium bicarbonate group, there is a significant difference in favor of the Ankaferd hemostat group in the mucositis grade on the 7th day and 15th day after chemotherapy (p < 0.05). In the binary logistic regression analysis, among the factors affecting the formation of mucositis on the 7th day, only neutrophil and thyroid-stimulating hormone (TSH) were included in the model, while only the TSH variable is statistically significant.

Conclusions

It was determined that Ankaferd hemostat is effective in preventing oral mucositis due to chemotherapy in adult patients diagnosed with colorectal cancer. In addition, it has been suggested to conduct new studies on the effectiveness of Ankaferd hemostat in the prevention of mucositis in different groups.

Trial registration

The study was registered at ClinicalTrials.gov (ID: NCT05438771, Date: 25.06.2022).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All data generated during this study are included in this published article.

References

  1. Dekker E, Tanis PJ, Vleugels JLA et al (2019) Colorectal cancer. Lancet 394(10207):1467–1480. https://doi.org/10.1016/S0140-6736(19)32319-0

    Article  PubMed  Google Scholar 

  2. Sonis S (2007) Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 5(9):3–11

    CAS  PubMed  Google Scholar 

  3. Al-Ansari S, Zecha JAEM, Barasch A et al (2015) Oral mucositis induced by anticancer therapies. Curr Oral Heal Rep 2:202–221. https://doi.org/10.1007/s40496-015-0069-4

    Article  Google Scholar 

  4. Gamelin BE, GueV DR et al (1999) Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: a potential ınterest for predicting 5-FU toxicity and determining optimal 5-FU dosage. J Clin Oncol 17(4):1105–1110

    Article  CAS  PubMed  Google Scholar 

  5. Ilhan Y, Sezgin Goksu S, Tatlı AM et al (2021) Does location of the tumor affect prognosis, survival, and relapse in patients with stage 3 colorectal cancers?. Akdeniz Med J 7(1):71–76. 10.17954

  6. Elting LS, Cooksley C, Chambers M et al (2003) The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98(7):1531–1539

    Article  PubMed  Google Scholar 

  7. Nomura M, Kamata M, Kojima H, Hayashi K, Sawada S (2013) Irsogladine maleate reduces the incidence of fluorouracil-based chemotherapy-induced oral mucositis. Ann Oncol 24(4):1062–1066. https://doi.org/10.1093/annonc/mds584

    Article  CAS  PubMed  Google Scholar 

  8. Lalla RV, Gordon GB, Schubert M et al (2012) A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy. Supportive Care in Cancer 20(8):1797–1804

    Article  PubMed  Google Scholar 

  9. Elad S, Karis Kin Fong CRVL, Yarom N et al (2020) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2020(1):4423–4431. https://doi.org/10.1002/cncr.33100

    Article  Google Scholar 

  10. Atay MH, Aslan NA, Aktimur S, Buyukkaya P, Kelkitli E (2015) Safety and efficacy of Ankaferd hemostat ( ABS ) in the chemotherapy-induced oral mucositis. UHOD 25:166–171. https://doi.org/10.4999/uhod.15811

    Article  CAS  Google Scholar 

  11. Goker H, Haznedaroglu I, Ercetın S et al (2008) Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper ®. J Int Med Res 36:163–170

    Article  CAS  PubMed  Google Scholar 

  12. Patıroglu T, Sahin E, Mustafa K et al (2018) Effectiveness of Ankaferd Blood Stopper in prophylaxis and treatment of oral mucositis in childhood cancers evaluated with plasma citrulline levels. Turk J Hematol 35(75–93):85–86. https://doi.org/10.4274/tjh.2017.0320

    Article  CAS  Google Scholar 

  13. Sattari A, Shariati A, Shakiba MN et al (2019) Comparative study of the effect of licorice root extract mouthwash and combined mouthwash on the incidence and severity of chemotherapy-induced mucositis symptoms in colon cancer patients admitted to intensive care units. Jundishapur Journal of Chronic Disease Care 8(3). https://doi.org/10.5812/jjcdc.88641

  14. Colin B, Cho M, Eastwood S et al (1996) Improving the quality of reporting of randomized controlled trials. JAMA 276(8):637–639. https://doi.org/10.1001/jama.1996.03540080059030

    Article  Google Scholar 

  15. Worthington H, Clarkson J, Bryan G et al (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev (4). The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. https://doi.org/10.1002/14651858.CD000978.pub5. Accessed 06 Jun 2023

  16. Cheeseman SL, Joel SP, Chester JD et al (2002) A ‘modified de Gramont’ regimen of fluorouracil, alone and withoxaliplatin, for advanced colorectal cancer. Br J Cancer 87(4):393–394

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chaveli-López B, Bagán-Sebastián J (2016) Treatment of oral mucositis due to chemotherapy. J Clin Exp Dent 8(2):e201–e209. https://doi.org/10.4317/jced.52917

    Article  PubMed  PubMed Central  Google Scholar 

  18. Celtek NY, Okan İ (2016) Patient evaluation and scales in palliative care. Klin Tıp Aile Hekim Derg 8(3):1–10

    Google Scholar 

  19. Valeh M, Kargar M, Mansouri A, Kamranzade H, Gholami K, Heidari K et al (2018) Factors affecting the incidence and severity of oral mucositis following hematopoietic stem cell. Int J Hematol Oncol Stem Cell Res 12(2):3–28

    Google Scholar 

  20. Saito H, Watanabe Y, Sato K et al (2014) Effects of professional oral health care on reducing the risk of chemotherapy-ınduced oral mucositis. Support Care Cancer 22:2935–2940. https://doi.org/10.1007/s00520-014-2282-4

    Article  PubMed  PubMed Central  Google Scholar 

  21. Turkish Society of Endocrinology and Metabolism Society (TEMD) (2019) Obesity diagnosis and treatment guide 2019, 8th edn. Turkish Society of Endocrinology and Metabolism. Ankara, Bayt Publishing, pp 21–22

    Google Scholar 

  22. Djuric M, Hillier-Kolarov V, Belic A, Jankovic L (2006) Mucositis prevention by improved dental care in acute leukemia patients. Support Care Cancer 14(2):137–146. https://doi.org/10.1007/s00520-005-0867-7

    Article  PubMed  Google Scholar 

  23. Resendea AHM, Farias JM, Silva DDB et al (2019) Application of biosurfactants and chitosan in toothpaste formulation. Colloids Surf, B 181:77–84

    Article  Google Scholar 

  24. Demir F, Ozsaker E, Ilce AO (2008) The quality and suitability of written educational materials for patients. J Clin Nurs 17(2):259–265

    Article  PubMed  Google Scholar 

  25. Charnock D, Shepperd S, Needham G, Gann R (1999) DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health 53(2):105–111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gokdoğan F, Ozcan A, Kır E et al (2003) Are training booklets available? In: 2 International 9 National Nursing Congress Antalya, Turkey, Congress Book, pp 545–549

  27. Ates A (2010) Educational software rating scale: validity and reliability study. IETC, p. 26–28. Available from: http://www.ajindex.com/dosyalar/makale/acarinde. date of access: 30.09.2021

  28. Veneziano L, Hooper J (1997) A method for quantifying content validity of health related questionnaires. Am J Health Behav 21(1):67–70

    Google Scholar 

  29. Ameen IHB, Alzubaidee AF, Majid S (2020) Comparative evaluation of the efficacy of ice cubes versus sodium bicarbonate mouthwash both as prophylactic measure and as treatment of oral mucositis induced by systemic anticancer therapies. Tabari Biomed Stud Res J 1(4):13–17. https://doi.org/10.18502/tbsrj.v1i4.2244

    Article  Google Scholar 

  30. Suresh AVS, Varma PP, Sinha S et al (2010) Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn]. J Cancer Res Ther 6(4):448–451. https://doi.org/10.4103/0973-1482.77100

    Article  CAS  PubMed  Google Scholar 

  31. Niikura N, Nakatukasa K, Amemiya T et al (2020) Oral care evaluation to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (Oral Care-BC): a randomized controlled phase III trial. Oncologist 25(2):220–230. https://doi.org/10.1634/theoncologist.2019-0382

    Article  CAS  Google Scholar 

  32. Leukemia and Lymphoma Society (LLS) (2016) Dental and oral complications of cancer treatment facts. Leukemia and Lymphoma Society 29:1–3. https://www.lls.org/treatment/managing. Accessed 05 May 2022

  33. Poulopoulos A, Papadopoulos P, Andreadis D (2017) Chemotherapy: oral side effects and dental interventions A review of the literature. Stomatological Dis Sci 1(2):35–49. https://doi.org/10.20517/2573-0002.2017.03

    Article  Google Scholar 

  34. Ministry of Republic of Turkey, Turkey oral and dental health profile research report -2018. Available from: https://shgm.saglik.gov.tr/Eklenti/42552/0/tadsppdf.pdf?_date of access: 01.05.2023

  35. Zheng Z, Zhao X, Zhao Q et al (2021) The effects of early nutritional ıntervention on oral mucositis and nutritional status of patients with head and neck cancer treated with radiotherapy. Front Oncol 10:1–11. https://doi.org/10.3389/fonc.2020.595632

    Article  Google Scholar 

  36. Chandna S, Bathla M (2011) Oral manifestations of thyroid disorders and its management. Indian J Endocrinol Metab. 15(12):113–116. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169868/pdf/IJEM-15-113. Accessed 02.05.2022

  37. Loo WTY, Liu Q, Yip MCW et al (2013) Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients. Int J Biol Markers 28(2):168–173. https://doi.org/10.5301/jbm.5000025

    Article  CAS  PubMed  Google Scholar 

  38. Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2021) Thyroid hypofunction in aging testicular cancer survivors. Acta Oncol (Madr) 60(11):1452–1458. https://doi.org/10.1080/0284186X.2021.1958004

    Article  CAS  Google Scholar 

  39. Rodrigues A, Aguiar M, Oliveira P et al (2020) Effect of cryotherapy in preventing mucositis associated with the use of 5-fluorouracil. Rev Latino-Am Enfermagem 28(e3363):1–10. https://doi.org/10.1590/1518-8345.3953.3363

    Article  Google Scholar 

  40. Fatimah S, Sufiawati I, Wijaya I (2016) Characteristic patients with oral mucositis receiving 5-fu chemotherapy at Hasan Sadikin Hospital Bandung. Padjadjaran J Dent 28(3):205–209

    Article  Google Scholar 

  41. Huang C, Huang M, Fang P et al (2019) Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in headand neck cancer patients. Am J Clin Nutr 109:606–614

    Article  PubMed  PubMed Central  Google Scholar 

  42. Oh S, Kwon H, Lee S et al (2007) A phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (Modified FOLFOX-4) for gastric cancer patients with malignant ascites. Jpn J Clin Oncol 37(12):930–935

    Article  PubMed  Google Scholar 

  43. Pattanayak L, Panda N, Dash MK, Mohanty S, Samantaray S (2016) Management of chemoradiation-induced mucositis in head and neck cancers with oral glutamine. J Glob Oncol 2(4):200–206. https://doi.org/10.1200/jgo.2015.000786

    Article  PubMed  PubMed Central  Google Scholar 

  44. Velden V, Herbers A, Netea M, Blijlevens N (2014) Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol 167(4):441–452. https://doi.org/10.1111/bjh.13113

    Article  PubMed  Google Scholar 

  45. Satheeshkumar PS, El-dallal M, Mohan MP (2021) Feature selection and predicting chemotherapy-induced ulcerative mucositis using machine learning methods. Int J Med Informatics 154:1–9

    Article  Google Scholar 

  46. Anmar AT, Al-Shohani AD, Albasry Z, Altaee A (2019) Current topical trends and novel therapeutic approaches and delivery systems for oral mucositis management. J Pharm Bioall Sci 12:94–101. https://doi.org/10.4103/jpbs.JPBS

    Article  Google Scholar 

  47. Kazemıan A, Kamıan S, Aghılı M et al (2008) Benzydamine for prophylaxis of radiation-ınduced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. Eur J Cancer Care 18:174–178

    Article  Google Scholar 

  48. Adibi SS, Alcorn JL, Ono K, Lichtenberger LM (2018) Gender and smoking correlations of surfactant lipids and proteins in the saliva of dental patients. J Dent Maxillofac Surg 1(1):67–70. https://doi.org/10.18314/jdms.v1i1.1385

    Article  PubMed  PubMed Central  Google Scholar 

  49. Lorini L, Perri F, Vecchio S et al (2022) Confounding factors in the assessment of oral mucositis in head and neck cancer. Support Care Cancer 30(10):8455–8463. https://doi.org/10.1007/s00520-022-07128-w

    Article  PubMed  PubMed Central  Google Scholar 

  50. Feng L, Wang L (2013) Effects of alcohol on the morphological and structural changes in oral mucosa. Pakistan J Med Sci 29(4):1046–1049. https://doi.org/10.12669/pjms.294.3696

    Article  Google Scholar 

  51. Pöschl G, Stickel F, Wang XD, Seitz HK (2004) Alcohol and cancer: genetic and nutritional aspects. Proceedings of the Nutrition Society 63(1):65–71. https://doi.org/10.1079/pns2003323

    Article  PubMed  Google Scholar 

  52. Schiött C, Höe H (1970) The origin and variation in number of leukocytes in thehuman saliva. J Periodont Res 5:36–41

    Article  Google Scholar 

  53. Kumar N, Burke M, Brooke A et al (2018) The oral management of oncology patients requiring radiotherapy, chemotherapy and / or bone marrow transplantation. clinical guideline. Fac Den J:1–85. https://www.rcseng.ac.uk/-/media/files/rcs/fds/publication. Accessed 20 Apr 2022

  54. Gebri E, Kiss A, Tóth F, Hortobágyi T (2020) Female sex as an independent prognostic factor in the development of oral mucositis during autologous peripheral stem cell transplantation. Sci Rep 10(1):1–12. https://doi.org/10.1038/s41598-020-72592-5

    Article  CAS  Google Scholar 

  55. Mortezaee K, Ahmadi A, Haghi-Aminjan H et al (2019) Thyroid function following breast cancer chemotherapy: a systematic review. J Cell Biochem 120(8):12101–12107. https://doi.org/10.1002/jcb.28771

    Article  CAS  PubMed  Google Scholar 

  56. Schmidberger H, Rave-Fränk M, Kim S et al (2003) Radiation-induced mucositis and neutrophil granulocytes in oral mucosa. Strahlenther Onkol 179:667–672. https://doi.org/10.1007/s00066-003-1121-1

    Article  PubMed  Google Scholar 

  57. Cabrera-Jaimea S, Martínezc C, Ferro-García T et al (2018) Efficacy of plantago major, chlorhexidine 0.12% and sodium bicarbonate 5% solution in the treatment of oral mucositis in cancer patients with solid tumour: a feasibility randomised triple-blind phase III clinical trial. Europ J Oncol Nurs 32:40–47. https://doi.org/10.1016/j.ejon.2017.11.006

    Article  Google Scholar 

Download references

Acknowledgements

Paper extracted from doctoral thesis “The effects of Ankaferd Hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy,” presented to Bursa Uludag University Health Science Faculty, Bursa, Turkey. The research team would like to extend their gratitude to this university and all the participants who made this project possible.

Author information

Authors and Affiliations

Authors

Contributions

YK participated in the study design, data collection, data analysis, and implementation of the study; HY participated in the study design, analysis, and manuscript revision and supervised the research; YK provided an initial draft of the manuscript and participated in analysis, interpretation of data, and manuscript revision; HY, TE, and ICH participated in the study design and data analysis; ICH participated in the study design, analysis, and interpretation of data. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Yasemin Karacan.

Ethics declarations

Ethics approval and consent to participate

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Bursa Uludag University (Date.2020/ No.4/21–1). Informed consent was obtained from all individual participants included in the study.

Consent for publication

Patients signed informed consent regarding publishing their data and photographs.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karacan, Y., Yıldız, H., Evrensel, T. et al. The effects of Ankaferd hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy. Support Care Cancer 31, 385 (2023). https://doi.org/10.1007/s00520-023-07856-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00520-023-07856-7

Keywords

Navigation